Skip to main content
Log in

Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Background: The aim was to analyse the magnitude, direction and predictors of change in the main hospital discharge diagnosis (HDD) after a clinical expert review, among patients included in a multicentre molecular epidemiologic study of biliopancreatic diseases. Methods: A total of 602 patients with a suspicion diagnosis of pancreas cancer (PC), cancer of the extrahepatic biliary system (CEBS) or benign biliopancreatic pathologies (BPP) were prospectively recruited at five general hospitals. A structured form was used to collect information from medical records. A panel of experts revised all diagnostic information and established the main clinico-pathological diagnosis (CPD) by consensus. Results: Of the 204 cases with a HDD of PC, 176 (86%) were deemed to have a CPD of PC, eight of CEBS, twelve a neoplasm of different origin, four BPP and four syndromic diagnoses. Thus, 28 cases (14%) were false positives. Of the 129 patients with a HDD of CEBS, 15 (12%) were false positives. Nine of the 396 cases with a HDD of non-PC (2%) had a CPD of PC (false negatives), whilst 14 of 471 patients with a HDD of non-CEBS (3%) were deemed to have CEBS. Overall, sensitivity and specificity of HDD for PC were, respectively, 95 and 93%, and for CEBS, 89 and 97%. Cytohistological confirmation and laparotomy were independent predictors of diagnostic change. Conclusions: Validity of the HDD was high, but its association with some clinical variables suggests that sole reliance on HDD can significantly bias results, and highlights the need to review all HDDs. Alternatively, only patients at high risk of misdiagnosis could be reviewed: primarily, those lacking a cytohistological diagnosis or a laparotomy. No exclusions appear warranted solely on the basis of age, gender or tumour spread.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson KE, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni FJ (eds), Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996: 725–793.

    Google Scholar 

  2. Parkin DM, Muir CS. Comparability and quality of data. In: Parkin DM, Muir CS, Whelan SL, et al. (eds) Cancer incidence in five continents. Volume VI. IARC Scientific Publications, No. 120, Lyon: International Agency for Research on Cancer, 1992: 45–173.

    Google Scholar 

  3. Porta M, Malats N, Piñol JL, Rifá J, Andreu M, Real FX, for the PANKRAS I Project Investigators. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. J Clin Epidemiol 1994; 47: 1069–1079.

    Google Scholar 

  4. Porta M, Malats N, Piñol JL, Real FX, Rifá J. Relevance of misclassification of disease status in epidemiologic studies of exocrine pancreatic cancer. Response to Silverman et al. [letter]. J Clin Epidemiol 1996; 49: 602–603.

    Google Scholar 

  5. Ojajärvi IA, Partanen TJ, Ahlbom A, et al. Occupational exposures and pancreatic cancer: A meta-analysis. Occup Environ Med 2000; 57: 316–324.

    Google Scholar 

  6. Weiderpass E, Partanen T, Kaaks R, et al. Occurrence, trends and environmental etiology of pancreatic cancer. Scand J Work Environ Health 1998; 24: 165–174.

    Google Scholar 

  7. International Classification of Diseases, Clinical Modification. 9th revision. Ann Arbor, MI: Commission on Professional and Hospital Activities, 1980.

    Google Scholar 

  8. Fraumeni JF, Devesa SS, McLaughlin JK, Stanford JL. Biliary tract cancer. In: Schottenfeld D, Fraumeni FJ (eds), Cancer epidemiology and prevention, 2nd ed. New York: Oxford University Press, 1996: 794–805.

    Google Scholar 

  9. Gloor B, Todd KE, Reber HA. Diagnostic workup of patients with suspected pancreatic carcinoma. Cancer 1997; 79: 1780–1786.

    Google Scholar 

  10. Rosewicz S, Wiedenmann B. Pancreatic carcinoma. Lancet 1997; 349: 485–489.

    Google Scholar 

  11. Brugge WR, Van Dam J. Pancreatic and biliary endoscopy. N Engl J Med 1999; 341: 1808–1816.

    Google Scholar 

  12. Niederau C, Grendell JH. Diagnosis of pancreatic carcinoma. Imaging techniques and tumour markers. Pancreas 1992; 7: 66–86.

    Google Scholar 

  13. Tan HP, Smith J, Garberoglio CA. Pancreatic adenocarcinoma: An update. J Am Coll Surg 1996; 183: 164–184.

    Google Scholar 

  14. Devita VT, Hellman S (eds) Cancer. Principles and practice of oncology, 5th ed. Philadelphia: Lippincott-Raven, 1997: 1065.

    Google Scholar 

  15. Burton EC, Troxclair DA, Newman WP. Autopsy diagnoses of malignant neoplasms. How often are clinical diagnoses incorrect? JAMA 1998; 280: 1245–1248.

    Google Scholar 

  16. Garabrant DH, Held J, Homa D. DDT and pancreatic cancer. Response to Malats et al. J Natl Cancer Inst 1993; 85: 328–329.

    Google Scholar 

  17. Rothman KJ, Greenland S (eds) Accuracy considerations in study design. In: Rothman KJ, Greenland S (eds), Modern epidemiology, 2nd ed. Philadelphia: Lippincott-Raven, 1998: 140–141.

  18. Mertens TE. Estimating the effects of misclassification. Lancet 1993; 342: 418–421.

    Google Scholar 

  19. Porta M, Malats N, Jariod M, et al. Serum levels of organochlorine compounds and K-ras mutations in 1 Principal investigator, 2 Centre Coordinator-Investigator, 3 Monitor, 4 Study reference pathologist. exocrine pancreatic cancer. Lancet 1999; 354: 2125–2129.

    Google Scholar 

  20. Porta M, Malats N, Guarner L, et al. Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. J Epidemiol Community Health 1999; 53: 702–709.

    Google Scholar 

  21. Soler M, Malats N, Porta M, et al. Medical conditions in patients with pancreatic and biliary diseases: Validity and agreement between data from questionnaires and medical records. Dig Dis Sci 1999; 44: 2469–2477.

    Google Scholar 

  22. Porta M, Jariod M, Malats N, et al. Prevalence of K-ras mutations at diagnosis and serum levels of DDT, DDE, PCBs and other organochlorine compounds in exocrine pancreatic cancer. In: Gress TM (ed), Molecular pathogenesis of pancreatic cancer. Amsterdam: IOS Press, 2000: 35–42.

    Google Scholar 

  23. Alguacil J, Kauppinen T, Porta M, et al. Risk of pancreatic cancer and occupational exposures in Spain. Ann Occup Hyg 2000; 44: 391–403.

    Google Scholar 

  24. Alguacil J, Porta M, Benavides FG, et al. Occupation and pancreatic cancer in Spain: A case-control study based on job titles. Int J Epidemiol 2000; 29 (in press).

  25. Soler M, Porta M, Malats N, et al. Learning from case-reports: Diagnostic issues in an epidemiologic study of pancreatic cancer. J Clin Epidemiol 1998; 51: 1215–1221.

    Google Scholar 

  26. Fletcher RH, Fletcher SW, Wagner EH. Clinical epidemiology. The essentials, 2nd ed. Baltimore: Williams & Wilkins, 1988: 55.

    Google Scholar 

  27. Weiss N. Clinical epidemiology, 2nd ed. New York: Oxford University Press, 1996: 20.

    Google Scholar 

  28. Feinstein AR. Clinical epidemiology. The architecture of clinical research. Philadelphia: WB Saunders, 1985: 439.

    Google Scholar 

  29. Grupo de Trabajo de la Sociedad Española de Epidemiología. La medición de la clase social en ciencias de la salud. Barcelona: SG Editores, 1995.

    Google Scholar 

  30. Armitage P, Berry G. Statistical methods in medical research, 2nd ed. Oxford: Blackwell, 1987: 125–132, 205–209.

    Google Scholar 

  31. Schlesselman JJ. Case-control studies. New York: Oxford University Press, 1982: 176–177.

    Google Scholar 

  32. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research. Belmont, CA: Lifetime Learning Publications, 1982: 343.

    Google Scholar 

  33. Silverman DT, Dunn JA, Hoover RN, et al. Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510–1516.

    Google Scholar 

  34. Silverman DT, Schiffman M, Devesa S. Diagnostic certainty in pancreatic cancer [letter]. J Clin Epidemiol 1996; 49: 602.

    Google Scholar 

  35. Riboli E, Stanta G, Delendi M, et al. Comparison between diagnoses of cancers of the stomach, colon, rectum, gall-bladder, liver and pancreas on death certificates and at autopsy in Trieste, 1970–1984. IARC Sci Pub No. 112. Lyon: International Agency for Research on Cancer 1991: 45–54.

    Google Scholar 

  36. Lyon JL, Robinson LM, Moser R Jr. Uncertainty in the diagnosis of histologically confirmed pancreatic cancer cases. Int J Epidemiol 1989; 18: 305–308.

    Google Scholar 

  37. Conlon CK, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathological analysis of 5–year survivors. Ann Surg 1996; 223: 273–279.

    Google Scholar 

  38. Alanen KA, Joensuu H. Long-term survival after pancreatic adenocarcinoma-often a misdiagnosis? Br J Cancer 1993; 1004–1005.

  39. Steinberg WM, Barkin J, Bradley EL, DiMagno E, Layer P. Controversies in clinical pancretology. Pancreas 1998; 17: 24–30.

    Google Scholar 

  40. Porta M, Malats N, Alguacil J, et al. Coffee, pancreatic cancer, and K-ras mutations: Updating the research agenda. J Epidemiol Community Health 2000; 54 (in press).

  41. Porta M, Malats N, Alguacil J, Soler M, Rifá J. La bÚsqueda de factores de riesgo para el cáncer de páncreas: práctica, paciencia y paradigmas. Gastroenterol Hepatol (Barc) 1997; 20: 259–273.

    Google Scholar 

  42. Porta M, Alvarez-Dardet C. Epidemiology: Bridges over (and across) roaring levels [editorial]. J Epidemiol Community Health 1998; 52: 605.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porta, M., Costafreda, S., Malats, N. et al. Validity of the hospital discharge diagnosis in epidemiologic studies of biliopancreatic pathology. Eur J Epidemiol 16, 533–541 (2000). https://doi.org/10.1023/A:1007692408457

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007692408457

Navigation